KCT0000407已完成未知
Evaluation of Immunogenicity and Safety of Hepatitis A Vaccine in Adolescents
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 13(Year) 至 18(Year)（—）
- 性别
- All
入选标准
- •1. Assessment of hepatitis A immunity
- •? adolescents(ages 13 to 18 years) who received Hepatitis A vaccine
- •in the past
- •2. Evaluation of the immunogenicity and safety after the hepatitis A vaccination and the receptivity to hepatitis A vaccination
- •? Adolescent who agree to this study and has no serum anti-HAV
- •? By the tester's judgement, Subject and/or subject's parent/legal
- •guardian of the subject are willing and able to follow instructions
- •? Before participating in this study, confirmed by medical history and
- •physical examination, subject should have no apparent health
- •? subject/subject's parent or legal guardian are willing and able to
- •provide written informed consent
- •? If the subject is a woman, she should have no childbearing potential
- •3. A Nationwide Survey on Acceptance of Hepatitis A Vaccination among Mothers of Children aged 7-18 Years in Korea.
- •? mothers of children and adolescents aged 7-18 years in 2013, who agreed ths telephone- based survey.
- •? mothers who did not vaccinate their child with hepatitis A vaccine
排除标准
- •1. Subject who have a history of allergic disease, or allergic reaction that can be exacerbated by the vaccine composition
- •2. Subject who have an acute illness(a moderate or severe disease
- •status with or without fever) at the time of registration
研究者
相似试验
已完成
2 期
Immunogenicity and safety of an adjuvant hepatitis B vaccine (fendrix) compared to Engerix in non-responding HIV-infected patientsefficacy and safety of 2 different hepatitis B vaccinations10047438NL-OMON36269Erasmus MC, Universitair Medisch Centrum Rotterdam50
进行中（未招募）
不适用
Immunogenicity and safety of an adjuvant hepatitis B vaccine (fendrix) compared to Engerix in non-responding HIV-infected patientsWe want to study the efficacy of Fendrix, a new adjuvant hepatitis B vaccin, in HIV infected patients, who failed to respond on intial standard and subsequent booster Hepatitis b vaccinations. We want to compare the efficacy of Fendrix to the efficacy of a double dose of the standard hepatitis b vaccinations, EngerixMedDRA version: 12.1Level: LLTClassification code 10002725Term: Anti-HIV positiveEUCTR2010-023946-58-NLErasmusMC
尚未招募
不适用
Characterization of immune responses in Hepatitis B patients experiencing a flare after stopping nucleot(s)ide analogue therapycHBVChronic hepatitis B1001965410047438NL-OMON50840Stichting Leveronderzoek50
已完成
不适用
Evaluation of the immunogenicity of thepentavalent vaccinepentavalent vaccine.IRCT2015051222234N1ational Institute for Medical Research Development1,200
尚未招募
2 期
Doxorubicin Transdrug® in Advanced Hepatocellular Carcinoma.HepatoCellular CarcinomaCancer - LiverACTRN12608000082303ORION Clinical Services (Australia) Pty Ltd200